The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 7
- 7 new
- Median first-year cost
- $799,493
- $4,917,000 in all
- Institutions
- 7
- 7 contact PIs
- Patents
- 2
- from 1 funded project
Awards by fiscal year
Fiscal years 2014 to 2026.
Most frequent institutions
- JOHNS HOPKINS UNIVERSITY1
- STANFORD UNIVERSITY1
- UNIVERSITY OF CALIFORNIA LOS ANGELES1
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO1
- UNIVERSITY OF TX MD ANDERSON CAN CTR1
and 2 other institutions
Most frequent study sections
- Special Emphasis Panel (ZCA1 RPRB-M (M1))7
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2015 | Imaging and Molecular Correlates of Progression in Cystic Neoplasms of the Pancreas1U01CA196403-01 | Maitra, Anirban | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | First-year cost $860,394 | Study section ZCA1 |
| FY2015 | Integrated Molecular, Cellular, and Imaging Characterization of Screen-Detected Lung Cancer1U01CA196408-01 | Aberle, Denise R.Duan, FenghaiDubinett, Steven M.Spira, Avrum E | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | First-year cost $812,527 | Study section ZCA1 |
| FY2015 | Multidiciplinary Integrative Genomic Approach to Distinguish Lethal from Indolent Prostate Cancer in Men of Europena and African Ancestry1U01CA196390-01 | De Marzo, Angelo MichaelPienta, Kenneth J. | JOHNS HOPKINS UNIVERSITY, MD | First-year cost $809,998 | Study section ZCA1 |
| FY2015 | Stanford Molecular and Cellular Characterization Laboratory1U01CA196387-01 | Brooks, James D. | STANFORD UNIVERSITY, CA | First-year cost $799,493 | Study section ZCA1 |
| FY2015 | Elucidating the molecular and contextual basis for IDLE ultralow risk lesions and the tumor immune microenvironment of high risk in situ and invasive breast cancers1U01CA196406-01 | Esserman, Laura J | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | First-year cost $796,788 | Study section ZCA1 |
| FY2015 | Vermont Breast Cancer Molecular Characterization Laboratory1U01CA196383-01 | Sprague, Brian LStein, Janet LWeaver, Donald Lee | UNIVERSITY OF VERMONT & ST AGRIC COLLEGE, VT | First-year cost $717,240 | Study section ZCA1 |
| FY2015 | Cellular, molecular and quantitative imaging analysis of screening-detected lung adenocarcinoma1U01CA196405-01 | Massion, Pierre P. | VANDERBILT UNIVERSITY, TN | First-year cost $120,560 | Study section ZCA1 |
Patents from its funded projects
2 patents name 1 of the 7 funded projects.
- US 11,946,928 (opens the patent at USPTO, a PDF, in a new tab)METHODS AND COMPOSITIONS RELATING TO AIRWAY DYSFUNCTIONGranted April 2, 2024 to Trustees of Boston University and THE BRIGHAM AND WOMEN'S HOSPITAL, INC.U01CA196408 · UNIVERSITY OF CALIFORNIA LOS ANGELES, CA
- US 11,579,140 (opens the patent at USPTO, a PDF, in a new tab)METHODS RELATED TO BRONCHIAL PREMALIGNANT LESION SEVERITY AND PROGRESSIONGranted February 14, 2023 to Trustees of Boston University and HEALTH RESEARCH, INC.U01CA196408 · UNIVERSITY OF CALIFORNIA LOS ANGELES, CA
Each number opens the patent at USPTO, beside the project NIH ties it to and that project's institution. NIH ties a patent to a project, not to a year of its funding, and says its list is incomplete. The grant date and the owners are USPTO's: the organizations the patent names as assignees on the day it was granted. Source: United States Patent and Trademark Office, www.uspto.gov, which does not endorse ScienceDex.
Data: Grants.gov's daily extract and NIH's notice pages, award files and patents file, in ScienceGraph release conductgrants-2026-11-13-0.3.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.